These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16168134)

  • 1. Early stopping of clinical trials.
    Cuzick J; Howell A; Forbes J
    Breast Cancer Res; 2005; 7(5):181-3. PubMed ID: 16168134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential clinical trials in cancer research.
    George SL
    Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data handling in clinical trials: an ongoing debate.
    Jongen PJ
    Mult Scler; 1995; 1 Suppl 1():S60-3. PubMed ID: 9345402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim futility analysis with intermediate endpoints.
    Goldman B; LeBlanc M; Crowley J
    Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring the safety of participants in randomised clinical trials: basis and methods].
    Tijssen JG
    Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current controversies in data monitoring for clinical trials.
    Pocock SJ
    Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning for closeout--from Day One.
    Shepherd R; Macer JL; Grady D
    Contemp Clin Trials; 2008 Mar; 29(2):136-9. PubMed ID: 17644047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical researchers and the pharmaceutical industry. Usefulness and need for an independent steering committee].
    Van Gijn J; Algra A
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1477-9. PubMed ID: 10443264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
    Monnier A
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1355-9. PubMed ID: 17069521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach.
    Berry DA; Ho CH
    Biometrics; 1988 Mar; 44(1):219-27. PubMed ID: 3358990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the use of adaptive clinical trial designs.
    Emerson SS
    Stat Med; 2006 Oct; 25(19):3270-96; discussion 3302-4, 3320-5, 3326-47. PubMed ID: 16906553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patient safety in clinical intervention research].
    Brekelmans CT; Kenter MJ; Bouter LM; Koëter GH
    Ned Tijdschr Geneeskd; 2011; 155():A2359. PubMed ID: 21342593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for monitoring efficacy and toxicity responses in clinical trials.
    Cook RJ; Farewell VT
    Biometrics; 1994 Dec; 50(4):1146-52. PubMed ID: 7786995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.